184 related articles for article (PubMed ID: 35738902)
1. Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes.
Mc Larney BE; Zhang Q; Pratt EC; Skubal M; Isaac E; Hsu HT; Ogirala A; Grimm J
J Nucl Med; 2023 Jan; 64(1):177-182. PubMed ID: 35738902
[TBL] [Abstract][Full Text] [Related]
2. (68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.
Fan D; Zhang X; Zhong L; Liu X; Sun Y; Zhao H; Jia B; Liu Z; Zhu Z; Shi J; Wang F
Bioconjug Chem; 2015 Jun; 26(6):1054-60. PubMed ID: 25853280
[TBL] [Abstract][Full Text] [Related]
3. Cerenkov luminescence imaging of medical isotopes.
Ruggiero A; Holland JP; Lewis JS; Grimm J
J Nucl Med; 2010 Jul; 51(7):1123-30. PubMed ID: 20554722
[TBL] [Abstract][Full Text] [Related]
4. Comparative immuno-Cerenkov luminescence and -PET imaging enables detection of PSMA
Maier FC; Wild AM; Kirchen N; Holm F; Fuchs K; Schwenck J; Maurer A; Wiehr S
Appl Radiat Isot; 2019 Jan; 143():149-155. PubMed ID: 30445280
[TBL] [Abstract][Full Text] [Related]
5. In situ lymphoma imaging in a spontaneous mouse model using the Cerenkov Luminescence of F-18 and Ga-67 isotopes.
Ritter Z; Zámbó K; Balogh P; Szöllősi D; Jia X; Balázs Á; Taba G; Dezső D; Horváth I; Alizadeh H; Tuch D; Vyas K; Hegedűs N; Kovács T; Szigeti K; Máthé D; Schmidt E
Sci Rep; 2021 Dec; 11(1):24002. PubMed ID: 34907289
[TBL] [Abstract][Full Text] [Related]
6.
Costa PF; Püllen L; Kesch C; Krafft U; Tschirdewahn S; Moraitis A; Radtke JP; Ting S; Nader M; Wosniack J; Kersting D; Lückerath K; Herrmann K; Fendler WP; Hadaschik BA; Darr C
J Nucl Med; 2023 Apr; 64(4):598-604. PubMed ID: 36357181
[TBL] [Abstract][Full Text] [Related]
7. Radiation Protection and Occupational Exposure on
Costa PF; Fendler WP; Herrmann K; Sandach P; Grafe H; Grootendorst MR; Püllen L; Kesch C; Krafft U; Radtke JP; Tschirdewahn S; Hadaschik BA; Darr C
J Nucl Med; 2022 Sep; 63(9):1349-1356. PubMed ID: 34916249
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Cerenkov Luminescence Imaging (CLI) Comparable With 3-D PET Standard Measurements.
Habte F; Natarajan A; Paik DS; Gambhir SS
Mol Imaging; 2018; 17():1536012118788637. PubMed ID: 30043654
[TBL] [Abstract][Full Text] [Related]
9. Cerenkov Luminescence Imaging (CLI) for cancer therapy monitoring.
Xu Y; Liu H; Chang E; Jiang H; Cheng Z
J Vis Exp; 2012 Nov; (69):e4341. PubMed ID: 23183774
[TBL] [Abstract][Full Text] [Related]
10. Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model.
Maier FC; Schmitt J; Maurer A; Ehrlichmann W; Reischl G; Nikolaou K; Handgretinger R; Pichler BJ; Thaiss WM
Oncotarget; 2016 Oct; 7(41):67403-67411. PubMed ID: 27602580
[TBL] [Abstract][Full Text] [Related]
11. Multispectral Cerenkov luminescence tomography for small animal optical imaging.
Spinelli AE; Kuo C; Rice BW; Calandrino R; Marzola P; Sbarbati A; Boschi F
Opt Express; 2011 Jun; 19(13):12605-18. PubMed ID: 21716501
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Light Imaging Using Cerenkov Luminescence and Liquid Scintillation for Preclinical Optical Imaging In Vivo.
Shimamoto M; Gotoh K; Hasegawa K; Kojima A
Mol Imaging Biol; 2016 Aug; 18(4):500-9. PubMed ID: 26819217
[TBL] [Abstract][Full Text] [Related]
13. Innovations in Nuclear Imaging Instrumentation: Cerenkov Imaging.
Tamura R; Pratt EC; Grimm J
Semin Nucl Med; 2018 Jul; 48(4):359-366. PubMed ID: 29852945
[TBL] [Abstract][Full Text] [Related]
14. Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
Timmermand OV; Tran TA; Strand SE; Axelsson J
J Nucl Med; 2015 Mar; 56(3):444-9. PubMed ID: 25655628
[TBL] [Abstract][Full Text] [Related]
15. Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model.
Robertson R; Germanos MS; Manfredi MG; Smith PG; Silva MD
J Nucl Med; 2011 Nov; 52(11):1764-9. PubMed ID: 21994410
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions.
Holland JP; Normand G; Ruggiero A; Lewis JS; Grimm J
Mol Imaging; 2011 Jun; 10(3):177-86, 1-3. PubMed ID: 21496448
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL.
Natarajan A; Habte F; Liu H; Sathirachinda A; Hu X; Cheng Z; Nagamine CM; Gambhir SS
Mol Imaging Biol; 2013 Aug; 15(4):468-75. PubMed ID: 23471750
[TBL] [Abstract][Full Text] [Related]
18. Cerenkov imaging - a new modality for molecular imaging.
Thorek DLj; Robertson R; Bacchus WA; Hahn J; Rothberg J; Beattie BJ; Grimm J
Am J Nucl Med Mol Imaging; 2012; 2(2):163-73. PubMed ID: 23133811
[TBL] [Abstract][Full Text] [Related]
19. Radiopharmaceutical and Eu
Shi X; Cao C; Zhang Z; Tian J; Hu Z
J Nanobiotechnology; 2021 Jul; 19(1):212. PubMed ID: 34271928
[TBL] [Abstract][Full Text] [Related]
20. A review of recent and emerging approaches for the clinical application of Cerenkov luminescence imaging.
Mc Larney B; Skubal M; Grimm J
Front Phys; 2021; 9():. PubMed ID: 36845872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
